Pneumocystis jirovecii pneumonia (PCP) typically presents as an interstitial and alveolar process with ground glass opacities on chest computed tomography (CT). e absence of ground glass opacities on chest CT is thought to have a high negative predictive value for PCP in individuals with AIDS. Here, we report a case of PCP in a man with AIDS who presented to our hospital with subacute shortness of breath and a nonproductive cough. While his chest CT revealed di use nodular rather than ground glass opacities, bronchoscopy with bronchoalveolar lavage and transbronchial biopsies con rmed the diagnosis of PCP and did not identify additional pathogens. PCP was not the expected diagnosis based on chest CT, but it otherwise t well with the patient's clinical and laboratory presentation. In the era of combination antiretroviral therapy, routine prophylaxis for PCP, and increased use of computed tomography, it may be that PCP will increasingly present with nonclassical chest radiographic patterns. Clinicians should be aware of this presentation when selecting diagnostic and management strategies.
Introduction
Pneumocystis jirovecii pneumonia (PCP) is a potentially lifethreatening infection that most often occurs in immunocompromised hosts. PCP was the most frequent complication of HIV/AIDS in the early phases of the epidemic, and while its incidence has declined substantially in the current era of combination antiretroviral therapy, it remains one of the most common HIV-associated opportunistic infections.
Generally, the diagnosis of PCP is suggested by a subacute illness featuring fever, nonproductive cough, malaise, and progressive shortness of breath [1] . Dyspnea and hypoxemia can be profound. Lung auscultation and chest roentgenogram can both be normal, but computed tomography (CT) of the chest typically demonstrates "ground glass opacities" [2, 3] .
is is likely due to the accumulation of cellular debris, brin, and organisms within the alveolar spaces [2] , as well as interstitial in ammation. Other radiographic patterns of PCP include a predilection for upper lobes (particularly in patients who use aerosolized pentamidine for prophylaxis), a preference for central rather than peripheral zones, and a tendency to form cysts [1, 4, 5] . Several serum tests can be used to help determine the likelihood of PCP, but microscopic visualization of induced sputum or bronchoalveolar lavage uid specimens remains the gold standard for diagnosis [6] .
A previous publication from our institution suggested that the presence of ground glass on high-resolution chest CT (HRCT) is 100% sensitive for PCP in patients with AIDS [7] . In other words, the absence of ground glass opacities on HRCT ruled out the diagnosis of PCP in such patients. Based on these data, our standard clinical practice has been to recommend against additional diagnostic testing and empiric PCP therapy for HIV-infected patients when their chest HRCT does not contain ground glass opacities, even in the setting of a clinical syndrome suggestive of PCP [8] .
Here, we report a case of PCP with an unusual radiographic appearance consisting of nodular opacities without ground glass on chest CT. While the clinical syndrome was convincing for PCP, the radiographic presentation made PCP seem unlikely and led to an interruption of PCP therapy.
Case Presentation
A 57-year-old man was admitted to our hospital with a fourweek history of nonproductive cough and dyspnea. His past medical history was notable for type II diabetes mellitus, chronic kidney disease with a baseline creatinine of 1.3 mg/dL, and untreated HIV/AIDS, which had been diagnosed 20 years previously. Prior opportunistic infections included oral candidiasis and cryptococcal meningitis. He was allergic to sulfonamides and had been prescribed dapsone for PCP prophylaxis, but he was not taking it reliably. His most recent known CD4 count and HIV viral load, 11 months prior to admission, were 15 cells/uL and 148,582 copies/mL, respectively.
Four days prior to presenting to our emergency department, the patient was admitted to another hospital with the same symptoms of nonproductive cough and shortness of breath. Chest radiograph at that time showed di use micronodules, greater in the right lung ( Figure 1 ). ere, he was empirically treated for both community-acquired pneumonia and PCP with ceftriaxone, azithromycin, clindamycin, primaquine, and steroids. He was also given uconazole for thrush. Unfortunately, he left that facility against medical advice after 48 hours. He took no further treatment before coming to our hospital two days later.
When he subsequently came to our emergency department complaining of ongoing shortness of breath and cough, temperature was 35.9 degree Celsius, heart rate 119 beats per minute, blood pressure 107/71 mmHg, respiratory rate 18 breaths per minute, and oxygen saturation 96% while breathing ambient air. He was ill-appearing with conjunctival pallor and oral thrush. e remainder of his physical examination was normal, including chest auscultation, which revealed good air movement without wheezing, rales, or rhonchi. Laboratory analysis was notable for white blood cell count of 6,200 cells/uL with 63% neutrophils, 19% lymphocytes, 13% monocytes, and 3% eosinophils, elevated lactate dehydrogenase of 385 u/L, and positive beta-D-glucan of 389 pg/mL (Table 1) . Chest roentgenogram revealed di use micronodules with conuent areas of nodular opacities ( Figure 2 ). On the basis of these ndings, the patient was admitted to our medical service and treated empirically for community-acquired pneumonia with ceftriaxone and doxycycline, for thrush with uconazole, and for PCP with clindamycin and primaquine.
On hospital day 2, the patient developed worsening shortness of breath with hypoxemia requiring supplemental oxygen. A noncontrast, volumetric chest CT scan ( Figure 3 ) revealed di use micronodules with central cavitation and bronchial wall thickening, most suspicious for mycobacterial or fungal infection. Notably, there were no ground glass opacities. Based on this CT and the lack of ground glass opacities, the treating team discontinued PCP therapy, initiated tuberculosis treatment, and consulted the pulmonary service for assistance and consideration of bronchoscopy. e patient underwent bronchoscopy with bronchoalveolar lavage (BAL) and transbronchial biopsy the following day. Pathologic analysis of the transbronchial biopsy specimen demonstrated foamy exudates on hematoxylin and eosin-(H&E-) stained sections, and silver stain revealed Pneumocystis jirovecii-type fungal organisms con rming the diagnosis to be PCP [9] (Figure 4) . No concurrent infections were found on cultures or pathologic samples (Table 2 ). e patient was treated with three weeks of clindamycin, primaquine, and prednisone. He was discharged home on hospital day 10 without requiring supplemental oxygen and did well thereafter, with a resolution of radiographic abnormalities on imaging obtained four months later ( Figure 5 ).
Discussion
Although the incidence of PCP has decreased since the advent of combination antiretroviral therapy in the 1990s, it remains among the most common pulmonary opportunistic infections in patients with AIDS. PCP should be suspected in the clinical setting of subacute dyspnea, nonproductive cough, and fever. While microscopic visualization of bronchoalveolar lavage uid is the gold standard for diagnosing PCP, chest CT is increasingly being used to make clinical decisions about empiric treatment, and whether to pursue bronchoscopy. e radiographic appearance of PCP can vary from person to person. e "classic" presentation on plain lm is of bilateral, symmetric opacities in an interstitial or alveolar pattern [3, 10] . Chest CT in patients with AIDS who develop PCP most often shows ground glass opacities [2, 4, 11, 12] . However, PCP has also been described to present infrequently with additional ndings including cystic lung disease, pneumothoraces, and nodules, among other patterns [2, 3, 13] .
It is not entirely surprising that PCP can have a variety of radiographic presentations. As a pathogen that primarily causes disease in the immunosuppressed, PCP often occurs in lungs that have been damaged by prior infections, distorting their architecture. Moreover, it is not uncommon for PCP to co-occur with another infection in an immunocompromised host. In such a circumstance, the radiographic signature of PCP may be subsumed by the coinfecting pathogen.
At our institution where we have extensive experience caring for patients with HIV/AIDS, a chest CT without ground glass is generally thought to "rule out" PCP in patients with AIDS.
is is based on a 1997 study of 51 patients with AIDS and a clinical syndrome consistent with PCP but normal chest roentgenogram who underwent HRCT of the chest [7] . In this cohort, the absence of ground glass opacities on chest CT had a perfect negative predictive value for Pneumocystis pneumonia (i.e., the presence of ground glass was 100% sensitive for PCP). Knowing these data and subsequent clinical experience, the team treating the described patient was surprised to learn that the patient had PCP, and PCP alone-as the absence of ground glass opacities on chest CT was highly unusual. Indeed, the treating clinicians decided to discontinue PCP-directed therapy on the basis of the CT ndings. While highly atypical, the radiographic appearance of the described patient's PCP is not entirely without precedent. Some of the previously mentioned publications do describe rare instances of PCP presenting as nodules [2] [3] [4] 10] . Still, such described presentations were the exception rather than the rule, and over the past 20 years, all cases of PCP that we have seen at our institution have consistently manifested as ground glass opacities on chest CT (when obtained).
It is likely that we, and others, will encounter more cases of PCP with "atypical" radiographic presentations. e increased access to CT scanners means more patients are undergoing chest CT for indications that previously may not have led to such imaging. Our patient, for example, with subacute cough, dyspnea, fevers, and malaise had a clinical history consistent with PCP, and his chest roentgenogram with regions of con uent nodular opacities could have been interpreted as typical of PCP. Based on the inclusion criteria for the aforementioned 1997 study [7] from our institution, our patient would have proceeded directly to sputum induction or bronchoscopy on the basis of his clinical history and chest roentgenogram, without rst having undergone chest CT. If that course had been taken, he would have been discovered to have PCP in the setting of a compatible clinical history and imaging (plain lm) and his presentation would have been considered entirely typical. We would not have appreciated the exclusively nodular aspect of his disease.
Beyond the increased availability of cross-sectional imaging with chest CT, increased access to combination antiretroviral therapy and PCP prophylaxis may also alter the radiographic appearance of PCP [3] . Even in patients with inconsistent treatment adherence, the degree of immunosuppression, extent of opportunistic infection, and radiographic presentation of PCP may not be directly comparable to those with HIV who are treatment-naive.
In the case of the patient we describe, his two days of therapy with clindamycin and primaquine at the referring hospital could theoretically have altered his chest CT nding and explained the lack of ground glass opacities. However, this seems highly unlikely because (1) his plain lms on admission to each institution were similar and (2) he worsened clinically after receiving the initial PCP-directed therapy.
is worsening, which is often seen with PCP, suggests a robust alveolar and interstitial in ammatory response, which we would expect to cause more, not fewer, ground glass opacities on chest CT.
In summary, we describe a case of PCP in a patient with AIDS, with classic presenting symptoms but an unusual radiographic pattern on chest CT featuring nodular opacities and no ground glass. e lack of ground glass opacities resulted in brief PCP treatment interruption. CT scan ndings alone should not be used to discontinue PCPspeci c treatment, particularly in patients with a clinical syndrome that is otherwise consistent with PCP. Case Reports in Infectious Diseases 5
